Schild SE - Search Results

1

Seizures Prior to Whole-brain Irradiation for Metastatic Disease: Prevalence, Risk Factors and Association With Survival.

Rades D, Witteler J, Dziggel L, Kjaer TW, Tvilsted S, Schild SE. Rades D, et al. Among authors: schild se. Anticancer Res. 2020 Jun;40(6):3429-3434. doi: 10.21873/anticanres.14328. Anticancer Res. 2020. PMID: 32487641

2

Defining the optimal dose of radiation after incomplete resection of central neurocytomas.

Rades D, Schild SE, Ikezaki K, Fehlauer F. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):373-7. doi: 10.1016/s0360-3016(02)03918-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12527050

3

Treatment of atypical neurocytomas.

Rades D, Fehlauer F, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2004 Feb 15;100(4):814-7. doi: 10.1002/cncr.20032. Cancer. 2004. PMID: 14770439 Free article. Review.

4

Prognostic value of the MIB-1 labeling index for central neurocytomas.

Rades D, Schild SE, Fehlauer F. Rades D, et al. Among authors: schild se. Neurology. 2004 Mar 23;62(6):987-9. doi: 10.1212/01.wnl.0000115392.21898.e3. Neurology. 2004. PMID: 15037708

5

Therapy of meningeal melanocytomas.

Rades D, Schild SE, Tatagiba M, Molina HA, Alberti W. Rades D, et al. Among authors: schild se. Cancer. 2004 Jun 1;100(11):2442-7. doi: 10.1002/cncr.20296. Cancer. 2004. PMID: 15160350 Free article.

6

A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.

Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE, Schmoll HJ, Karstens JH, Alberti W. Rades D, et al. Among authors: schild se. Cancer. 2004 Dec 1;101(11):2687-92. doi: 10.1002/cncr.20633. Cancer. 2004. PMID: 15493037 Free article. Clinical Trial.

7

Defining the best available treatment for neurocytomas in children.

Rades D, Schild SE, Fehlauer F. Rades D, et al. Among authors: schild se. Cancer. 2004 Dec 1;101(11):2629-32. doi: 10.1002/cncr.20695. Cancer. 2004. PMID: 15494975 Free article.

8

Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.

Rades D, Fehlauer F, Ikezaki K, Schild SE. Rades D, et al. Among authors: schild se. Radiother Oncol. 2005 Jan;74(1):67-9. doi: 10.1016/j.radonc.2004.08.008. Radiother Oncol. 2005. PMID: 15683672

9

Well-differentiated neurocytoma: what is the best available treatment?

Rades D, Fehlauer F, Lamszus K, Schild SE, Hagel C, Westphal M, Alberti W. Rades D, et al. Among authors: schild se. Neuro Oncol. 2005 Jan;7(1):77-83. doi: 10.1215/S1152851704000584. Neuro Oncol. 2005. PMID: 15701284 Free PMC article.

10

Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels.

Rades D, Schild SE, Bahrehmand R, Zschenker O, Alberti WA, Rudat VR. Rades D, et al. Among authors: schild se. Cancer. 2005 Apr 15;103(8):1740-6. doi: 10.1002/cncr.20952. Cancer. 2005. PMID: 15742330 Free article.

11

Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.

Rades D, Schild SE, Yekebas EF, Job H, Schwarz R, Rudat V. Rades D, et al. Among authors: schild se. Cancer. 2005 Jun 1;103(11):2274-9. doi: 10.1002/cncr.21042. Cancer. 2005. PMID: 15852356 Free article.

12

Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. Rades D, et al. Among authors: schild se. J Clin Oncol. 2005 May 20;23(15):3366-75. doi: 10.1200/JCO.2005.04.754. J Clin Oncol. 2005. PMID: 15908648

13

Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.

Rades D, Veninga T, Stalpers LJ, Schulte R, Hoskin PJ, Poortmans P, Schild SE, Rudat V. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):182-8. doi: 10.1016/j.ijrobp.2005.06.036. Epub 2005 Sep 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16198069

14

Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature.

Rades D, Schild SE. Rades D, et al. Among authors: schild se. J Neurooncol. 2006 May;77(3):311-4. doi: 10.1007/s11060-005-9048-2. Epub 2005 Dec 3. J Neurooncol. 2006. PMID: 16328723 Review.

15

Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2006 Mar 1;106(5):1140-3. doi: 10.1002/cncr.21628. Cancer. 2006. PMID: 16400638 Free article.

16

Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.

Rades D, Hoskin PJ, Stalpers LJ, Schulte R, Poortmans P, Veninga T, Dahm-Daphi J, Obralic N, Wildfang I, Bahrehmand R, Engenhart-Cabilic R, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1452-7. doi: 10.1016/j.ijrobp.2005.10.018. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16413695

17

Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.

Rades D, Walz J, Stalpers LJ, Veninga T, Schulte R, Obralic N, Wildfang I, Engenhart-Cabilic R, Hoskin PJ, Schild SE. Rades D, et al. Among authors: schild se. Eur Urol. 2006 May;49(5):846-52; discussion 852. doi: 10.1016/j.eururo.2005.11.004. Epub 2005 Dec 19. Eur Urol. 2006. PMID: 16442206

18

Treatment recommendations for the various subgroups of neurocytomas.

Rades D, Schild SE. Rades D, et al. Among authors: schild se. J Neurooncol. 2006 May;77(3):305-9. doi: 10.1007/s11060-005-9047-3. Epub 2006 Mar 31. J Neurooncol. 2006. PMID: 16575540 Review.

19

Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.

Rades D, Stalpers LJ, Schulte R, Veninga T, Basic H, Engenhart-Cabilic R, Schild SE, Hoskin PJ. Rades D, et al. Among authors: schild se. Eur J Cancer. 2006 May;42(8):1052-6. doi: 10.1016/j.ejca.2005.12.022. Epub 2006 Mar 31. Eur J Cancer. 2006. PMID: 16580192

20

Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.

Rades D, Tribius S, Yekebas EF, Bahrehmand R, Wildfang I, Kilic E, Muellerleile U, Gross E, Schild SE, Alberti W. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):459-65. doi: 10.1016/j.ijrobp.2005.12.019. Epub 2006 Apr 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16584851 Clinical Trial.

21

Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2006 Jul;182(7):415-8. doi: 10.1007/s00066-006-1522-z. Strahlenther Onkol. 2006. PMID: 16826361

22

Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.

Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. J Clin Oncol. 2006 Jul 20;24(21):3388-93. doi: 10.1200/JCO.2005.05.0542. J Clin Oncol. 2006. PMID: 16849752

23

Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.

Rades D, Fehlauer F, Wroblesky J, Albers D, Schild SE, Schmidt R. Rades D, et al. Among authors: schild se. Oral Oncol. 2007 Jul;43(6):535-43. doi: 10.1016/j.oraloncology.2006.05.006. Epub 2006 Sep 26. Oral Oncol. 2007. PMID: 17005437

24

Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.

Rades D, Fehlauer F, Veninga T, Stalpers LJ, Basic H, Hoskin PJ, Rudat V, Karstens JH, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):532-7. doi: 10.1016/j.ijrobp.2006.08.047. Epub 2006 Nov 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17084539

25

Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.

Rades D, Karstens JH, Hoskin PJ, Rudat V, Veninga T, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):525-31. doi: 10.1016/j.ijrobp.2006.09.025. Epub 2006 Dec 4. Int J Radiat Oncol Biol Phys. 2007. PMID: 17141977

26

Radiotherapy of metastatic spinal cord compression in very elderly patients.

Rades D, Hoskin PJ, Karstens JH, Rudat V, Veninga T, Stalpers LJ, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):256-63. doi: 10.1016/j.ijrobp.2006.08.011. Int J Radiat Oncol Biol Phys. 2007. PMID: 17189074

27

Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.

Rades D, Veninga T, Stalpers LJ, Basic H, Rudat V, Karstens JH, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. J Clin Oncol. 2007 Jan 1;25(1):50-6. doi: 10.1200/JCO.2006.08.7155. J Clin Oncol. 2007. PMID: 17194905

28

Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.

Rades D, Schulte R, Yekebas EF, Homann N, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2007 Jan;183(1):10-6. doi: 10.1007/s00066-007-1583-7. Strahlenther Onkol. 2007. PMID: 17225940

29

Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.

Rades D, Veninga T, Stalpers LJ, Basic H, Hoskin PJ, Karstens JH, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1506-9. doi: 10.1016/j.ijrobp.2006.11.029. Epub 2007 Feb 1. Int J Radiat Oncol Biol Phys. 2007. PMID: 17275201

30

Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.

Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2007 Jun 15;109(12):2515-21. doi: 10.1002/cncr.22729. Cancer. 2007. PMID: 17487853 Free article.

31

Is stereotactic radiosurgery the best treatment option for patients with spinal metastases?

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Nat Clin Pract Oncol. 2007 Jul;4(7):400-1. doi: 10.1038/ncponc0846. Epub 2007 May 29. Nat Clin Pract Oncol. 2007. PMID: 17534288 No abstract available.

32

Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?

Rades D, Walz J, Schild SE, Veninga T, Dunst J. Rades D, et al. Among authors: schild se. Urology. 2007 Jun;69(6):1081-5. doi: 10.1016/j.urology.2007.02.045. Urology. 2007. PMID: 17572191

33

Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.

Rades D, Schwarz R, Todorovic M, Thurmann H, Graefen M, Walz J, Schild SE, Dunst J, Alberti W. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2007 Jul;183(7):398-402. doi: 10.1007/s00066-007-1643-z. Strahlenther Onkol. 2007. PMID: 17609874 Clinical Trial.

34

Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.

Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ, Dunst J. Rades D, et al. Among authors: schild se. Cancer. 2007 Sep 1;110(5):1077-82. doi: 10.1002/cncr.22877. Cancer. 2007. PMID: 17614294 Free article.

35

Is surgery necessary following chemoradiation for patients with locally advanced cancer of the esophagus?

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Nat Clin Pract Oncol. 2007 Sep;4(9):506-7. doi: 10.1038/ncponc0897. Epub 2007 Jul 10. Nat Clin Pract Oncol. 2007. PMID: 17622234 No abstract available.

36

Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.

Rades D, Haatanen T, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Cancer. 2007 Sep 15;110(6):1345-50. doi: 10.1002/cncr.22906. Cancer. 2007. PMID: 17639588 Free article.

37

A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.

Rades D, Pluemer A, Veninga T, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2007 Oct 1;110(7):1551-9. doi: 10.1002/cncr.22960. Cancer. 2007. PMID: 17654659 Free article.

38

Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer.

Rades D, Fehlauer F, Sheikh-Sarraf M, Kazic N, Basic H, Poorter R, Hakim SG, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Head Neck. 2008 Feb;30(2):235-41. doi: 10.1002/hed.20683. Head Neck. 2008. PMID: 17657790

39

Reduction of overall treatment time in patients irradiated for more than three brain metastases.

Rades D, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1509-13. doi: 10.1016/j.ijrobp.2007.05.014. Epub 2007 Aug 6. Int J Radiat Oncol Biol Phys. 2007. PMID: 17689033

40

Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.

Rades D, Kuhn H, Schultze J, Homann N, Brandenburg B, Schulte R, Krull A, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1087-93. doi: 10.1016/j.ijrobp.2007.07.2364. Epub 2007 Sep 24. Int J Radiat Oncol Biol Phys. 2008. PMID: 17892921

41

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.

Rades D, Lohynska R, Veninga T, Stalpers LJ, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2007 Dec 1;110(11):2587-92. doi: 10.1002/cncr.23082. Cancer. 2007. PMID: 17893909 Free article.

42

Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.

Rades D, Stoehr M, Kazic N, Hakim SG, Walz A, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1108-14. doi: 10.1016/j.ijrobp.2007.07.2380. Epub 2007 Oct 1. Int J Radiat Oncol Biol Phys. 2008. PMID: 17905528

43

Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.

Rades D, Pluemer A, Veninga T, Hanssens P, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2007 Nov 15;110(10):2285-92. doi: 10.1002/cncr.23037. Cancer. 2007. PMID: 17922523 Free article.

44

The first score predicting overall survival in patients with metastatic spinal cord compression.

Rades D, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2008 Jan 1;112(1):157-61. doi: 10.1002/cncr.23150. Cancer. 2008. PMID: 17948910 Free article.

45

Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).

Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2007 Nov;183(11):631-6. doi: 10.1007/s00066-007-1763-5. Strahlenther Onkol. 2007. PMID: 17960339

46

The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.

Rades D, Golke H, Schild SE, Kilic E. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9. doi: 10.1016/j.ijrobp.2007.09.027. Epub 2007 Oct 29. Int J Radiat Oncol Biol Phys. 2008. PMID: 17967510

47

Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer.

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Nat Clin Pract Oncol. 2008 Mar;5(3):128-9. doi: 10.1038/ncponc1017. Nat Clin Pract Oncol. 2008. PMID: 18043603 No abstract available.

48

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 Jan;184(1):30-5. doi: 10.1007/s00066-008-1795-5. Strahlenther Onkol. 2008. PMID: 18188520

49

Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.

Rades D, Setter C, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1134-42. doi: 10.1016/j.ijrobp.2007.11.006. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258387 Clinical Trial.

50

A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer.

Rades D, Schild SE. Rades D, et al. Among authors: schild se. Nat Clin Pract Oncol. 2008 Apr;5(4):190-1. doi: 10.1038/ncponc1076. Epub 2008 Feb 19. Nat Clin Pract Oncol. 2008. PMID: 18285761 No abstract available.

51

Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.

Rades D, Kieckebusch S, Haatanen T, Lohynska R, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1319-24. doi: 10.1016/j.ijrobp.2007.08.009. Int J Radiat Oncol Biol Phys. 2008. PMID: 18374222

52

Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.

Rades D, Stoehr M, Meyners T, Bohlen G, Nadrowitz R, Dunst J, Schild SE, Wroblewski J, Albers D, Schmidt R, Alberti W, Tribius S. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 Apr;184(4):198-205. doi: 10.1007/s00066-008-1825-3. Strahlenther Onkol. 2008. PMID: 18398584

53

A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.

Rades D, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 May;184(5):251-5. doi: 10.1007/s00066-008-1831-5. Strahlenther Onkol. 2008. PMID: 18427755

54

A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.

Rades D, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):905-8. doi: 10.1016/j.ijrobp.2008.02.018. Epub 2008 Apr 23. Int J Radiat Oncol Biol Phys. 2008. PMID: 18436390

55

Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression.

Rades D, Lange M, Veninga T, Rudat V, Bajrovic A, Stalpers LJ, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):228-34. doi: 10.1016/j.ijrobp.2008.04.044. Epub 2008 Jun 6. Int J Radiat Oncol Biol Phys. 2009. PMID: 18539406 Clinical Trial.

56

Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.

Rades D, Rudat V, Veninga T, Stalpers LJ, Hoskin PJ, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2008 Sep 1;113(5):1090-6. doi: 10.1002/cncr.23702. Cancer. 2008. PMID: 18642349 Free article.

57

A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.

Rades D, Kueter JD, Pluemer A, Veninga T, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1077-81. doi: 10.1016/j.ijrobp.2008.05.035. Epub 2008 Aug 15. Int J Radiat Oncol Biol Phys. 2009. PMID: 18707817

58

Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy.

Rades D, Golke H, Schild SE, Kilic E. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 Aug;184(8):416-20. doi: 10.1007/s00066-008-1850-2. Strahlenther Onkol. 2008. PMID: 18956519

59

Comparison of different treatment approaches for one to two brain metastases in elderly patients.

Rades D, Pluemer A, Veninga T, Schild SE. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 Nov;184(11):565-71. doi: 10.1007/s00066-008-1908-1. Epub 2008 Nov 19. Strahlenther Onkol. 2008. PMID: 19016014

60

Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis.

Rades D, Kueter JD, Veninga T, Gliemroth J, Schild SE. Rades D, et al. Among authors: schild se. Eur J Cancer. 2009 Feb;45(3):400-4. doi: 10.1016/j.ejca.2008.10.033. Epub 2008 Dec 4. Eur J Cancer. 2009. PMID: 19062269

61

Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.

Rades D, Kueter JD, Hornung D, Veninga T, Hanssens P, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2008 Dec;184(12):655-62. doi: 10.1007/s00066-008-1946-8. Epub 2008 Dec 24. Strahlenther Onkol. 2008. PMID: 19107346

62

Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy.

Rades D, Wolff C, Nadrowitz R, Breunig C, Schild SE, Baehre M, Meller B. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1226-31. doi: 10.1016/j.ijrobp.2008.12.029. Epub 2009 Apr 6. Int J Radiat Oncol Biol Phys. 2009. PMID: 19356858

63

Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.

Rades D, Fischer D, Veninga T, Stalpers LJ, Schild SE. Rades D, et al. Among authors: schild se. Gynecol Oncol. 2009 Sep;114(3):506-8. doi: 10.1016/j.ygyno.2009.05.030. Epub 2009 Jun 21. Gynecol Oncol. 2009. PMID: 19540574

64

Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.

Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):537-41. doi: 10.1016/j.ijrobp.2009.05.001. Epub 2009 Sep 3. Int J Radiat Oncol Biol Phys. 2010. PMID: 19733017

65

Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

Tribius S, Kronemann S, Kilic Y, Schroeder U, Hakim S, Schild SE, Rades D. Tribius S, et al. Among authors: schild se. Strahlenther Onkol. 2009 Oct;185(10):675-81. doi: 10.1007/s00066-009-1992-x. Epub 2009 Oct 6. Strahlenther Onkol. 2009. PMID: 19806333

66

The role of postoperative radiotherapy for the treatment of gangliogliomas.

Rades D, Zwick L, Leppert J, Bonsanto MM, Tronnier V, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2010 Jan 15;116(2):432-42. doi: 10.1002/cncr.24716. Cancer. 2010. PMID: 19908258 Free article.

67

Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).

Bohlen G, Meyners T, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Rades D. Bohlen G, et al. Among authors: schild se. Clin Neurol Neurosurg. 2010 Apr;112(3):183-7. doi: 10.1016/j.clineuro.2009.11.004. Epub 2009 Dec 3. Clin Neurol Neurosurg. 2010. PMID: 19962229

68

Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?

Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, Rowland KM Jr, Bearden JD. Schild SE, et al. Am J Clin Oncol. 2010 Dec;33(6):633-6. doi: 10.1097/COC.0b013e3181c4c54b. Am J Clin Oncol. 2010. PMID: 20042969 Free PMC article.

69

Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Heisterkamp C, Haatanen T, Schild SE, Rades D. Heisterkamp C, et al. Among authors: schild se. Strahlenther Onkol. 2010 Feb;186(2):70-75. doi: 10.1007/s00066-010-2067-8. Epub 2010 Jan 26. Strahlenther Onkol. 2010. PMID: 20127223

70

Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.

Rades D, Meyners T, Veninga T, Stalpers LJ, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):404-8. doi: 10.1016/j.ijrobp.2009.07.1717. Epub 2010 Feb 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171794

71

Treatment of painful bone metastases.

Rades D, Schild SE, Abrahm JL. Rades D, et al. Among authors: schild se. Nat Rev Clin Oncol. 2010 Apr;7(4):220-9. doi: 10.1038/nrclinonc.2010.17. Epub 2010 Mar 16. Nat Rev Clin Oncol. 2010. PMID: 20234353 Review.

72

Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.

Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Rudat V, Schild SE, Dunst J, Rades D. Freundt K, et al. Among authors: schild se. Strahlenther Onkol. 2010 Apr;186(4):218-23. doi: 10.1007/s00066-010-2110-9. Epub 2010 Mar 26. Strahlenther Onkol. 2010. PMID: 20354660

73

Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis.

Rades D, Kronemann S, Meyners T, Schild SE, Hakim SG. Rades D, et al. Among authors: schild se. Oral Oncol. 2010 Jul;46(7):549-52. doi: 10.1016/j.oraloncology.2010.04.002. Oral Oncol. 2010. PMID: 20435508

74

Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Rades D, Setter C, Dunst J, Dahl O, Schild SE, Noack F. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2010 Jun;186(6):307-14. doi: 10.1007/s00066-010-2131-4. Epub 2010 Apr 26. Strahlenther Onkol. 2010. PMID: 20437013

75

Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression.

Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):524-30. doi: 10.1016/j.ijrobp.2009.10.073. Epub 2010 May 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20452136

76

Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?

Rades D, Heisterkamp C, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):398-403. doi: 10.1016/j.ijrobp.2009.08.022. Epub 2010 May 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 20488627

77

Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression.

Rades D, Douglas S, Veninga T, Stalpers LJ, Hoskin PJ, Bajrovic A, Adamietz IA, Basic H, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2010 Aug 1;116(15):3670-3. doi: 10.1002/cncr.25223. Cancer. 2010. PMID: 20564129 Free article.

78

Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors.

Rades D, Freundt K, Meyners T, Bajrovic A, Basic H, Karstens JH, Adamietz IA, Wildfang I, Rudat V, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1492-7. doi: 10.1016/j.ijrobp.2010.04.026. Epub 2010 Jun 25. Int J Radiat Oncol Biol Phys. 2011. PMID: 20579816

79

Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression.

Rades D, Douglas S, Huttenlocher S, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Adamietz IA, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1503-6. doi: 10.1016/j.ijrobp.2010.01.024. Epub 2010 Jun 3. Int J Radiat Oncol Biol Phys. 2011. PMID: 20605351

80

Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression.

Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, Schild SE. Rades D, et al. Among authors: schild se. J Clin Oncol. 2010 Aug 1;28(22):3597-604. doi: 10.1200/JCO.2010.28.5635. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606090

81

Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck.

Rades D, Kronemann S, Meyners T, Bohlen G, Tribius S, Kazic N, Schroeder U, Hakim SG, Schild SE, Dunst J. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1037-44. doi: 10.1016/j.ijrobp.2010.03.033. Epub 2010 Jul 16. Int J Radiat Oncol Biol Phys. 2011. PMID: 20638185

82

Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases.

Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1122-7. doi: 10.1016/j.ijrobp.2010.03.031. Epub 2010 Jul 16. Int J Radiat Oncol Biol Phys. 2011. PMID: 20638188 Clinical Trial.

83

Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):499-505. doi: 10.1016/j.ijrobp.2010.02.003. Epub 2010 Jun 18. Int J Radiat Oncol Biol Phys. 2011. PMID: 20646855

84

Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC).

Rades D, Nadrowitz R, Buchmann I, Hunold P, Noack F, Schild SE, Meller B. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2010 Aug;186(8):458-62. doi: 10.1007/s00066-010-2153-y. Epub 2010 Jul 29. Strahlenther Onkol. 2010. PMID: 20803287

85

Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):442-7. doi: 10.1016/j.ijrobp.2010.08.048. Epub 2010 Oct 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 20950963

86

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.

Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJ, Schild SE, Rades D. Meyners T, et al. Among authors: schild se. BMC Cancer. 2010 Oct 26;10:582. doi: 10.1186/1471-2407-10-582. BMC Cancer. 2010. PMID: 20977700 Free PMC article.

87

Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors.

Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Adamietz IA, Kazic N, Rudat V, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e861-8. doi: 10.1016/j.ijrobp.2010.11.056. Epub 2011 Jan 27. Int J Radiat Oncol Biol Phys. 2011. PMID: 21277114

88

Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.

Rades D, Evers JN, Veninga T, Stalpers LJ, Lohynska R, Schild SE. Rades D, et al. Among authors: schild se. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e469-73. doi: 10.1016/j.ijrobp.2011.01.058. Epub 2011 Apr 7. Int J Radiat Oncol Biol Phys. 2011. PMID: 21477949

89

The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F. Rades D, et al. Among authors: schild se. Cancer. 2012 Jan 1;118(1):157-63. doi: 10.1002/cncr.26282. Epub 2011 Jun 28. Cancer. 2012. PMID: 21713768 Free article.

90

Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - results of a matched-pair analysis.

Rades D, Schroeder U, Bajrovic A, Schild SE. Rades D, et al. Among authors: schild se. Eur J Cancer. 2011 Dec;47(18):2729-34. doi: 10.1016/j.ejca.2011.06.013. Epub 2011 Jul 2. Eur J Cancer. 2011. PMID: 21726998

91

Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.

Rades D, Veninga T, Hornung D, Wittkugel O, Schild SE, Gliemroth J. Rades D, et al. Among authors: schild se. Cancer. 2012 Feb 15;118(4):1138-44. doi: 10.1002/cncr.26379. Epub 2011 Jul 14. Cancer. 2012. PMID: 21761403 Free article.

92

Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.

Rades D, Meyners T, Kazic N, Bajrovic A, Rudat V, Schild SE. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2011 Sep;187(9):541-7. doi: 10.1007/s00066-011-2262-2. Epub 2011 Aug 16. Strahlenther Onkol. 2011. PMID: 21858415

93

Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Rades D, Seibold ND, Gebhard MP, Noack F, Schild SE, Thorns C. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2011 Oct;187(10):626-32. doi: 10.1007/s00066-011-1139-8. Epub 2011 Sep 19. Strahlenther Onkol. 2011. PMID: 21932027

94

Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.

Rades D, Hornung D, Veninga T, Schild SE, Gliemroth J. Rades D, et al. Among authors: schild se. Cancer. 2012 Jun 1;118(11):2980-5. doi: 10.1002/cncr.26612. Epub 2011 Oct 25. Cancer. 2012. PMID: 22027993 Free article.

95

Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis.

Rades D, Panzner A, Rudat V, Karstens JH, Schild SE. Rades D, et al. Among authors: schild se. Strahlenther Onkol. 2011 Nov;187(11):729-35. doi: 10.1007/s00066-011-2266-y. Epub 2011 Oct 28. Strahlenther Onkol. 2011. PMID: 22037654

96

Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.

Rades D, Kueter JD, Meyners T, Pluemer A, Veninga T, Gliemroth J, Schild SE. Rades D, et al. Among authors: schild se. Clin Neurol Neurosurg. 2012 May;114(4):326-30. doi: 10.1016/j.clineuro.2011.10.042. Epub 2011 Dec 5. Clin Neurol Neurosurg. 2012. PMID: 22152784

97

Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis.

Rades D, Panzner A, Dziggel L, Haatanen T, Lohynska R, Schild SE. Rades D, et al. Among authors: schild se. Cancer. 2012 Aug 1;118(15):3852-9. doi: 10.1002/cncr.26680. Epub 2011 Dec 13. Cancer. 2012. PMID: 22170514 Free article.

98

Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D. Douglas S, et al. Among authors: schild se. BMC Cancer. 2012 Jun 21;12:261. doi: 10.1186/1471-2407-12-261. BMC Cancer. 2012. PMID: 22720880 Free PMC article.

99

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer.

Rades D, Douglas S, Veninga T, Schild SE. Rades D, et al. Among authors: schild se. BMC Cancer. 2012 Jul 20;12:302. doi: 10.1186/1471-2407-12-302. BMC Cancer. 2012. PMID: 22817686 Free PMC article.

100

A new score predicting the survival of patients with spinal cord compression from myeloma.

Douglas S, Schild SE, Rades D. Douglas S, et al. Among authors: schild se. BMC Cancer. 2012 Sep 25;12:425. doi: 10.1186/1471-2407-12-425. BMC Cancer. 2012. PMID: 23009630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page